Acciones Alterola Biotech, Inc. Other OTC
Acciones
ABTI
US02152V1035
Biotecnología e investigación médica
Ventas 2022 | - | Ventas 2023 | - | Capitalización | 35,27 M 32,98 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -6 M -5,61 M | Resultado Neto 2023 | -1 M -935 mil | VE / Ventas 2022 | - |
Deuda neta 2022 | 199 mil 186 mil | Deuda neta 2023 | 1,41 M 1,31 M | VE / Ventas 2023 | - |
P/E ratio 2022 |
-26,2
x | P/E ratio 2023 |
-20,2
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 56,4 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18/05/22 |
Timothy Rogers
CHM | Chairman | 60 | 21/06/21 |
Colin Stott
COO | Chief Operating Officer | 57 | 21/06/21 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18/05/22 |
Nathan Thompson
BRD | Director/Board Member | - | 10/10/23 |
Daniel Reshef
BRD | Director/Board Member | 73 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |